← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 31, 2007First marketed drug
Mar 12, 2012First NDA
Mar 15, 2012Last known activity
Sep 6, 2023
Timeline
1980s
- Jan 1, 1985
Organogenesis— Founded
2010s
- Mar 12, 2012
erwinia asparaginase— NDA Secondary Org
- Mar 15, 2012
Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen— NDA Organization
- Mar 28, 2017
NuTech Medical, Inc— Acquired
Drugs by trial phase (6 distinct, 6 trials)
Phase 4 (0 own, 2 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (2)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (5)
- NCT06000410Lead sponsorPhase 3Sep 6, 2023
- NCT04636229Lead sponsorPhase 3Dec 14, 2020
- NCT03205436Lead sponsorN/AMay 1, 2017
- NCT01929954Lead sponsorPhase 1/Phase 2Jul 1, 2013
- NCT00587834Lead sponsorPhase 3Oct 31, 2007
Details
- Founded
- Canton, MA, US Jan 1, 1985
- First NDA
- Mar 15, 2012
- Last known activity
- Sep 6, 2023